CClinicalTrials.gg
CompletedNCT04279886Updated Jul 2, 2020

Three-dimensional Scanning of the Chest: a Comparison Between Three Different Imaging Modalities

An interventional study of Three-dimensional scans in Chest Wall Disorder, sponsored by Zuyderland Medisch Centrum. Completed at 1 site in Netherlands. Per ClinicalTrials.gov, last updated 2020-07-02.

Sponsored by Zuyderland Medisch Centrum · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Sex
All
01

Study summary

Recently, three-dimensional scanning of the torso has been proposed as an alternative for two-view chest radiographies and computed tomography to determine the severity of pectus excavatum without exposure to ionizing radiation. The range of three-dimensional scanning systems is broad with even varying systems being used within hospitals. Most of these scanning systems have been validated for accuracy and reproducibility, no comparison between these systems is known. In addition, severity measures of pectus excavatum, as well as other research outcomes, surgical planning techniques, and analysis methods are based on a single imaging system. It is subsequently essential to determine whether different imaging systems can be used interchangeably regarding accuracy and reproducibility.

The aim of this study was to assess the reproducibility and accuracy between three commonly used three-dimensional scanning systems.

02

Conditions studied

  • Chest Wall Disorder
03

In context

Lead sponsor

Zuyderland Medisch Centrum is the lead sponsor of 62 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy volunteers only

Exclusion criteria

Exclusion Criteria:

  • none
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Other
    Three-dimensional scan arm

    Other: Three-dimensional scans

Interventions

  • OtherThree-dimensional scans

    All included healthy volunteers received 6 three-dimensional scans, utilizing 3 different scanning systems (2 scans per system)

06

What researchers measure

Primary outcomes

  1. Reproducibility

    Mean difference between subsequent scans utilizing the same three-dimensional scanning system

    Time frame: 1 month

  2. Accuracy

    Mean difference between scans, acquired by different three-dimensional scanning systems

    Time frame: 1 month

07

Study locations

1 site
  • Zuyderland Medical Centre
    Heerlen, Limburg 6419PC, Netherlands
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04279886
Lead sponsor
Zuyderland Medisch Centrum
Collaborators
Radboud University Medical Center
Responsible party
Sponsor
First posted
Feb 21, 2020
Start date
Feb 20, 2020
Primary completion
Mar 20, 2020
Completion
Apr 20, 2020
Last update
Jul 2, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion